MVCAX
Price
$30.04
Change
-$0.44 (-1.44%)
Updated
Jun 13 closing price
Net Assets
16.57B
SPVZX
Price
$24.48
Change
-$0.32 (-1.29%)
Updated
Jun 13 closing price
Net Assets
157.04M
Interact to see
Advertisement

MVCAX vs SPVZX

Header iconMVCAX vs SPVZX Comparison
Open Charts MVCAX vs SPVZXBanner chart's image
MFS Mid Cap Value A
Price$30.04
Change-$0.44 (-1.44%)
VolumeN/A
Net Assets16.57B
PGIM Quant Solutions Mid-Cap Val Z
Price$24.48
Change-$0.32 (-1.29%)
VolumeN/A
Net Assets157.04M
MVCAX vs SPVZX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MVCAX vs. SPVZX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MVCAX is a Buy and SPVZX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MVCAX has more cash in the bank: 16.6B vs. SPVZX (157M). SPVZX pays higher dividends than MVCAX: SPVZX (1.69) vs MVCAX (0.89). MVCAX was incepted earlier than SPVZX: MVCAX (24 years) vs SPVZX (20 years). MVCAX (1.00) and SPVZX (1.00) have similar cost to investors . SPVZX is a more actively managed with annual turnover of: 97.00 vs. MVCAX (27.00). SPVZX has a lower initial minimum investment than MVCAX: SPVZX (0) vs MVCAX (1000). SPVZX annual gain was more profitable for investors over the last year : 6.33 vs. MVCAX (-4.53). SPVZX return over 5 years is better than : 91.38 vs. MVCAX (51.98).
MVCAXSPVZXMVCAX / SPVZX
Total Expense Ratio0.990.89111%
Annual Report Gross Expense Ratio1.001.00100%
Fund Existence24 years20 years-
Gain YTD-2.086-0.851245%
Front Load6%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets16.6B157M10,573%
Annual Yield % from dividends0.891.6953%
Returns for 1 year-4.536.33-72%
Returns for 3 years13.0024.1054%
Returns for 5 years51.9891.3857%
Returns for 10 years53.5132.18166%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GHRS12.76-0.07
-0.55%
GH Research PLC
WLK77.30-1.32
-1.68%
Westlake Corp
JBTM117.89-2.62
-2.17%
JBT Marel Corporation
INMB7.70-0.22
-2.78%
INmune Bio
TRIB0.63-0.04
-5.27%
Trinity Biotech plc